Articles by Rachel Grabenhofer

  1. What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 3 – Staying Aligned in a Moving System 6/23/2026

    Even strong plans fail without real-time alignment. As trials evolve, shared visibility, coordinated response, and early supply involvement keep execution on track.

  2. What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 2 – Where Assumptions Break Trials 6/16/2026

    Even strong plans fail without real-time alignment. As trials evolve, shared visibility, coordinated response, and early supply involvement keep execution on track.

  3. What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 1 – The Cost Of Late Involvement 6/9/2026

    Late involvement turns small gaps into costly problems. Bringing clinical supply in early improves planning, communication, and prevents downstream issues.

  4. Invisible Yet Accountable: How Clinical Supply Pressures Build Strategic Leaders 6/1/2026

    Clinical supply leaders operate under unseen pressure, balancing risk, uncertainty, and tradeoffs — building strategic judgment that drives trial success.

  5. From Invisible to Integral: Inviting Clinical Supply Expertise to the Planning Table 6/1/2026

    Clinical supply leaders bring resilience, adaptability, and judgment; integrating their expertise early in planning strengthens trial execution and strategic decision-making.

  6. Decision Authority And Direction — The Gap In Deviation Planning 5/27/2026

    Faster excursion detection improves supply visibility but also exposes an often-overlooked gap: a deviation plan outlining who has authority and what actions to take.

  7. Inside GCSG 2026: Clinical Supply Impact On Patient Experience 5/21/2026

    This GCSG 2026 event recap with Steve Jacobs (including video) highlights how clinical testing and supply decisions shape patient experience, among other buzzy topics.

  8. The cGMP Reality Of Clinical Supply For Advanced Therapies 5/5/2026

    Breakthrough therapies fail without cGMP‑ready supply. In cell and gene therapies, quality systems, timing, documentation and logistics dictate patient access.

  9. Putting Vaccine Supply Resilience To The Test: The Last Mile 4/29/2026

    This second in a two-part series describes how the resilience of a global vaccine network shaped clinical supply is challenged up to the last mile: at clinical sites.

  10. How Clinical Supply Drives Resilience In Global Vaccine Networks 4/29/2026

    This article is the first in a two-part series exploring how clinical supply's ability to integrate processes drives resilience in global vaccine programs.